Panel Discussion: Optimal Duration of DAPT - How to Optimize Future Study Designs

Sunday, February 26, 2023

5:42 PM – 5:55 PM ET

Panel Moderator(s)

Alexandre A. Abizaid, MD, PhD

Director of Invasive Cardiology
Incor
SÃO PAULO, Sao Paulo, Brazil

Disclosure(s): Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Robert A. Byrne, MD, BCh, PhD

Director of Cardiology
Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Dublin, Ireland

No relationships to disclose
Dean J. Kereiakes, MD, FACC, MSCAI

President, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

Disclosure(s): Elixir Medical: Consultant (Ongoing); JC Medical: Consultant (Ongoing); Orchestra Biomed: Consultant (Ongoing); Shockwave Medical Inc: Consultant (Ongoing); Svelte Medical: Consultant (Ongoing)

Panel Discussant(s)

Davide Capodanno, MD, PhD

Associate Professor
Division of Cardiology, CAST, "Policlinico-Vittorio Emanuele", University of Catania
Catania, Sicilia, Italy

Disclosure(s): No relevant disclosure to display
Ricardo A. Costa, MD, PhD

Interventional Cardiologist - Percutaneous Intervention Research Medical Section Chief
Institute Dante Pazzanese of Cardiology
Sao Paulo, Sao Paulo, Brazil

Disclosure(s): No financial relationships to disclose
Florim Cuculi, MD

Co-Chief Cardiology
Heart Center Lucerne

Disclosure information not submitted.
George Dangas, MD, MACC, MSCAI

PROFESSOR OF CARDIOLOGY
The Mount Sinai Hospital
New York, New York, United States

Disclosure information not submitted.
Ziyad Ghazzal, MD

Director, Heart and Vascular Outpatient Center
American University of Beirut Medical Center
American University of Beirut
Riad El Solh, Beyrouth, Lebanon

No relationships to disclose
Cara Hendry, MD FRCP LLM

Consultant Cardiologist
Manchester University NHS Foundation Trust
Bolton , England, United Kingdom

Disclosure(s): No financial relationships to disclose
Michael A. Kutcher, MD

Emeritus Professor of Internal Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States

No relationships to disclose
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

Professor of Medicine (Cardiology), and Population Health Science and Policy; Director of Interventional Cardiovascular Research and Clinical Trials
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Disclosure(s): Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)
Yoshinobu Onuma, MD, PhD (he/him/his)

Professor of Interventional Cardiology
National University of Ireland, Galway
Galway, Galway, Ireland

Disclosure(s): No financial relationships to disclose
Michael J. Rinaldi, MD

Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States

Disclosure(s): Abbott Vascular: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences LLC: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Scientific Advisory Board (Ongoing)
RR

Rafael Romaguera, MD

Staff
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Catalonia, Spain

Disclosure(s): Biosensors International: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor services fees (Ongoing); Boston Scientific Corp: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 29, 2023); CID: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 29, 2023)
Pieter C. Smits, PhD, FESC

Director Interventional Cardiology
Maasstad Ziekenhuis
Rotterdam, Netherlands

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Robert-Jan M. van Geuns, MD, PhD (he/him/his)

Cardiologist
RadboudUMC
Nijmegen, Gelderland, Netherlands

Disclosure(s): Abbot Vascular: Grants/Research Support Recipient (Ongoing); amgen: Grants/Research Support Recipient (Ongoing); Astra Zeneca: Grants/Research Support Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); sanofi: Grants/Research Support Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Alexandre A. Abizaid, MD, PhD: Boston Scientific: Proctor (Ongoing); Elixir Medical: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Dean J. Kereiakes, MD, FACC, MSCAI: Elixir Medical: Consultant (Ongoing); JC Medical: Consultant (Ongoing); Orchestra Biomed: Consultant (Ongoing); Shockwave Medical Inc: Consultant (Ongoing); Svelte Medical: Consultant (Ongoing)

Davide Capodanno, MD, PhD: No relevant disclosure to display

Ricardo A. Costa, MD, PhD: No financial relationships to disclose

Cara Hendry, MD FRCP LLM: No financial relationships to disclose

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI: Abbot, abiomed, alleviant medical, amgen, am-pharma, arena, AstraZeneca, Atricure: Grant/Research Support (Ongoing); Applied Therapeutics, Elixir Medical, Stel, ControlRad (spouse): Stock-privately held company (Ongoing); Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi: Grant/Research Support (Ongoing); Cine-Med Research, Ionis Pharmaceuticals, Novartis, Novo Nordisk, Vectura, WebMD: Consultant (Ongoing); Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Grant/Research Support (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Scientific Advisory Board (Ongoing)

Yoshinobu Onuma, MD, PhD: No financial relationships to disclose

Michael J. Rinaldi, MD: Abbott Vascular: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences LLC: Advisory Committee/Board Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Scientific Advisory Board (Ongoing)

Rafael Romaguera, MD: Biosensors International: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor services fees (Ongoing); Boston Scientific Corp: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 29, 2023); CID: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, January 29, 2023)

Pieter C. Smits, PhD, FESC: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Robert-Jan M. van Geuns, MD, PhD: Abbot Vascular: Grants/Research Support Recipient (Ongoing); amgen: Grants/Research Support Recipient (Ongoing); Astra Zeneca: Grants/Research Support Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); sanofi: Grants/Research Support Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)